XRN Chiron Real Estate Inc.
8-K Current Report
Filed: February 25, 2026
Financials
Real Estate Investment TrustsChiron Real Estate Inc. (XRN) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items4 items
- Item 2.02: Results of Operations and Financial Condition
- Item 5.03: Amendments to Articles of Incorporation or Bylaws
- Item 7.01: Regulation FD Disclosure
- Item 8.01: Other Events
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Q4 or full-year earnings press release referenced via exhibit — actual financial figures found only in the attached exhibit (likely Ex. 99.1)
- • Filing structured to limit legal liability — disclosure explicitly excluded from Section 18 Exchange Act coverage
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- • Name change only: Global Medical REIT Inc. → Chiron Real Estate Inc., effective Feb 23, 2026
- • Operating Partnership renamed from Global Medical REIT L.P. → Chiron Real Estate LP simultaneously
Item 7.01 · Regulation FD Disclosure
- • Reg FD boilerplate only — no material business, operational, or financial information disclosed in this filing section
Item 8.01 · Other Events
- • Ticker symbols changed Feb 23, 2026: common stock GMRE → XRN; preferred series A GMRE PrA → XRN PrA; preferred series B GMRE PrB → XRN PrB
- • Preferred stock terms unchanged: Series A carries 7.50% cumulative redeemable rate, Series B carries 8.00% cumulative redeemable rate
Other Chiron Real Estate Inc. 8-K Filings
Get deeper insights on Chiron Real Estate Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.